-
公开(公告)号:US20180030043A1
公开(公告)日:2018-02-01
申请号:US15551856
申请日:2016-02-17
申请人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARAIAH , Gutta MADHUSUDHAN , Komati SATYANARAYANA , Jakku MALLESWARA REDDY , MSN LABORATORIES PRIVATE LIMITED
发明人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARAIAH , Gutta MADHUSUDHAN , Komati SATYANA RAYAMA , Jakku MALLESWARA REDDY
IPC分类号: C07D417/12 , A61K9/16 , A61K31/5377 , C07C271/20 , C07C269/04
CPC分类号: C07D417/12 , A61K9/1611 , A61K9/1652 , A61K9/1682 , A61K31/5377 , C07C269/04 , C07C271/20 , C07D277/28
摘要: The present invention relates to novel processes for the preparation 1,3-Thiazol-5-ylmethyl[(2R,5R)-5-{[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl} carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl] carbamate having the following structural formula-1 and it's intermediates thereof.
-
公开(公告)号:US20190023655A1
公开(公告)日:2019-01-24
申请号:US15755993
申请日:2016-08-26
IPC分类号: C07D209/48
CPC分类号: C07D209/48 , C07B2200/13 , C07C315/04 , C07C317/28
摘要: The present invention, relates to solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide represented by the following structural formula-1 and process for their preparation. The present invention also relates to an improved process for the preparation of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide compound of formula-1 and intermediates thereof.
-
公开(公告)号:US20180298056A1
公开(公告)日:2018-10-18
申请号:US15568392
申请日:2016-04-22
申请人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARAIAH , Ghojala VENKAT REDDY , Katta LAXMI REDDY , MSN LABORATORIES PRIVATE LIMITED
CPC分类号: C07K5/1008 , C07K5/06078 , C07K5/0812 , C07K5/10 , C07K5/1016
摘要: The present invention relates to process for the preparation of (2S)—N—((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenyethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4- methylpentanamide represented by the following structural formula-1.
-
公开(公告)号:US20190144411A1
公开(公告)日:2019-05-16
申请号:US16202840
申请日:2018-11-28
IPC分类号: C07D309/10
摘要: The present invention provides a process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol which is represented by the following structural formula-1 and its glycerol solvate.
-
5.
公开(公告)号:US20170247331A1
公开(公告)日:2017-08-31
申请号:US15515109
申请日:2015-09-29
申请人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARAIAH , Gutta MADHUSUDHAN , MSN LABORATORIES PRIVATE LIMITED
IPC分类号: C07D213/81
CPC分类号: C07D213/81
摘要: The present invention relates to a process for the preparation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluophenoxy]-N-methylpyridine-2-carboxamide compound of formula-I, its amorphous form and its crystalline polymorph-I which is represented by the following structural formula: (I)
-
公开(公告)号:US20170247328A1
公开(公告)日:2017-08-31
申请号:US15509786
申请日:2015-09-08
IPC分类号: C07D211/22 , C07C51/367 , C07D263/24 , C07C51/06
CPC分类号: C07D211/22 , C07B2200/07 , C07C51/02 , C07C51/06 , C07C51/09 , C07C51/367 , C07C51/412 , C07D263/24 , C07C59/48
摘要: The present invention relates to an improved process for the preparation of [[2(S)-[[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid dihydrate, represented by the following structural formula (I).
-
公开(公告)号:US20180186784A1
公开(公告)日:2018-07-05
申请号:US15741086
申请日:2016-06-27
申请人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARIAH , Gutta MADHUSUDHAN , Peri SEETHA RAMA SARMA , Mogal KHALIL AHAMED , MSN LABORATORIES PRIVATE LIMITED
发明人: Srinivasan THIRUMALAI RAJAN , Sajja ESWARAIAH , Gutta MADHUSUDHAN , Peri SEETHA RAMA SARMA , Mogal KHALIL AHAMED
IPC分类号: C07D417/14 , C07C31/20 , B01D9/00
CPC分类号: C07D417/14 , B01D9/005 , C07B2200/13 , C07C31/205 , C07D417/12
摘要: The present invention relates to crystalline 1,2-Propanediol solvate of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide compound of formula-1b, its process for the preparation and its use in the preparation of anhydrous crystalline form (N-6) and monohydrate of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxy ethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide. [formula] 1,2-Propanediol solvate Formula-1b
-
-
-
-
-
-